Tim Kaine actually said...

If, in fact, we create programs that prevent people having access, then basically we get back to my earlier assumption of the presumption of...

I think that is a barrier that can be easily overcome, but it will require some collaboration, as I mentioned earlier.

Those who worked on the provision, we were having some real concerns about the way CMS is approaching it.

What regulatory barriers exist to making opioid related e-prescribing software more affordable and accessible to providers?